-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Pfizer, Raises Price Target to $30

Benzinga·11/04/2026 21:15:08
Listen to the news
Citigroup analyst Geoff Meacham maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $30.